HEADER HYDROLASE 11-AUG-05 2BZ6
TITLE ORALLY AVAILABLE FACTOR7A INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BLOOD COAGULATION FACTOR VIIA;
COMPND 3 CHAIN: H;
COMPND 4 FRAGMENT: FACTOR VII HEAVY CHAIN, RESIDUES 213-466;
COMPND 5 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA,
COMPND 6 PROCONVERTIN, EPTACOG ALFA, NOVOSEVEN;
COMPND 7 EC: 3.4.21.21;
COMPND 8 ENGINEERED: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: BLOOD COAGULATION FACTOR VIIA;
COMPND 11 CHAIN: L;
COMPND 12 FRAGMENT: FACTOR VII LIGHT CHAIN, RESIDUES 150-202;
COMPND 13 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA,
COMPND 14 PROCONVERTIN, EPTACOG ALFA, NOVOSEVEN;
COMPND 15 EC: 3.4.21.21;
COMPND 16 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 MOL_ID: 2;
SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 9 ORGANISM_COMMON: HUMAN;
SOURCE 10 ORGANISM_TAXID: 9606;
SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS SERINE PROTEASE, COAGULATION, ENZYME COMPLEX, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR K.GROEBKE-ZBINDEN,U.OBST-SANDER,K.HILPERT,H.KUEHNE,D.W.BANNER,
AUTHOR 2 H.J.BOEHM,M.STAHL,J.ACKERMANN,L.ALIG,L.WEBER,H.P.WESSEL,
AUTHOR 3 M.A.RIEDERER,T.B.TSCHOPP,T.LAVE
REVDAT 6 09-OCT-24 2BZ6 1 LINK
REVDAT 5 13-JUL-11 2BZ6 1 VERSN
REVDAT 4 24-FEB-09 2BZ6 1 VERSN
REVDAT 3 09-AUG-06 2BZ6 1 JRNL
REVDAT 2 22-MAR-06 2BZ6 1 JRNL
REVDAT 1 22-FEB-06 2BZ6 0
JRNL AUTH K.GROEBKE-ZBINDEN,D.W.BANNER,K.HILPERT,J.HIMBER,T.LAVE,
JRNL AUTH 2 M.A.RIEDERER,M.STAHL,T.B.TSCHOPP,U.OBST-SANDER
JRNL TITL DOSE-DEPENDANT ANTITHROMBOTIC ACTIVITY OF AN ORALLY ACTIVE
JRNL TITL 2 TISSUE FACTOR/FACTOR VIIA INHIBITOR WITHOUT CONCOMITANT
JRNL TITL 3 ENHANCEMENT OF BLEEDING PROPENSITY.
JRNL REF BIOORG.MED.CHEM. V. 14 5357 2006
JRNL REFN ISSN 0968-0896
JRNL PMID 16621574
JRNL DOI 10.1016/J.BMC.2006.03.042
REMARK 2
REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0005
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.32
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 90.2
REMARK 3 NUMBER OF REFLECTIONS : 58180
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.168
REMARK 3 R VALUE (WORKING SET) : 0.166
REMARK 3 FREE R VALUE : 0.193
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 3045
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64
REMARK 3 REFLECTION IN BIN (WORKING SET) : 4720
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2530
REMARK 3 BIN FREE R VALUE SET COUNT : 253
REMARK 3 BIN FREE R VALUE : 0.2740
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2370
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 36
REMARK 3 SOLVENT ATOMS : 500
REMARK 3
REMARK 3 B VALUES.
REMARK 3 B VALUE TYPE : LIKELY RESIDUAL
REMARK 3 FROM WILSON PLOT (A**2) : 22.00
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.77
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.51000
REMARK 3 B22 (A**2) : -0.51000
REMARK 3 B33 (A**2) : 1.03000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.071
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.074
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.048
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.579
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2562 ; 0.012 ; 0.021
REMARK 3 BOND LENGTHS OTHERS (A): 2284 ; 0.001 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3508 ; 1.462 ; 1.970
REMARK 3 BOND ANGLES OTHERS (DEGREES): 5313 ; 0.809 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 325 ; 6.355 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;30.692 ;23.178
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 407 ;12.051 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.793 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 382 ; 0.083 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2898 ; 0.006 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 526 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 464 ; 0.218 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2421 ; 0.193 ; 0.200
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1205 ; 0.174 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): 1567 ; 0.081 ; 0.200
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 351 ; 0.187 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 5 ; 0.076 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): 45 ; 0.191 ; 0.200
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.160 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2035 ; 0.904 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2572 ; 1.062 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1152 ; 1.660 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 936 ; 2.266 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : L 90 L 142
REMARK 3 ORIGIN FOR THE GROUP (A): 41.3280 27.2820 42.3810
REMARK 3 T TENSOR
REMARK 3 T11: -0.0557 T22: 0.0339
REMARK 3 T33: -0.0375 T12: 0.0118
REMARK 3 T13: 0.0082 T23: 0.0079
REMARK 3 L TENSOR
REMARK 3 L11: 4.6275 L22: 0.8105
REMARK 3 L33: 0.6293 L12: -0.1156
REMARK 3 L13: -0.3925 L23: 0.1547
REMARK 3 S TENSOR
REMARK 3 S11: 0.0454 S12: 0.1404 S13: 0.3046
REMARK 3 S21: -0.0432 S22: -0.0125 S23: -0.0703
REMARK 3 S31: -0.0375 S32: 0.0693 S33: -0.0329
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : H 16 H 257
REMARK 3 ORIGIN FOR THE GROUP (A): 19.6170 34.6540 38.2180
REMARK 3 T TENSOR
REMARK 3 T11: -0.0410 T22: 0.0070
REMARK 3 T33: -0.0808 T12: -0.0002
REMARK 3 T13: -0.0070 T23: -0.0042
REMARK 3 L TENSOR
REMARK 3 L11: 0.9350 L22: 1.0137
REMARK 3 L33: 0.8568 L12: -0.0545
REMARK 3 L13: 0.2156 L23: -0.0999
REMARK 3 S TENSOR
REMARK 3 S11: -0.0029 S12: 0.1156 S13: 0.0352
REMARK 3 S21: -0.0509 S22: -0.0037 S23: 0.0209
REMARK 3 S31: -0.0851 S32: 0.0283 S33: 0.0066
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS.
REMARK 4
REMARK 4 2BZ6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-05.
REMARK 100 THE DEPOSITION ID IS D_1290025286.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 25-FEB-00
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 8.50
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : BM1A
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.8
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH MAR300
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XDS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69242
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 81.6
REMARK 200 DATA REDUNDANCY : 7.000
REMARK 200 R MERGE (I) : 0.12000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.1500
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60
REMARK 200 COMPLETENESS FOR SHELL (%) : 36.5
REMARK 200 DATA REDUNDANCY IN SHELL : 5.80
REMARK 200 R MERGE FOR SHELL (I) : 0.81000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.780
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: ISOMORPHOUS TO 1W7X.PDB
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 60.20
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 35%AS, 2%PEG400, 100MM BICINE PH8.5,
REMARK 280 15% GLYCEROL, PH 8.50
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.82000
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.46500
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.46500
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.91000
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.46500
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.46500
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 86.73000
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.46500
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.46500
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 28.91000
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.46500
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.46500
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 86.73000
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.82000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 TOTAL BURIED SURFACE AREA: 2330 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 16580 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.9 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH H2100 LIES ON A SPECIAL POSITION.
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE2 GLU H 236 O HOH H 2357 1.84
REMARK 500 NE2 GLN H 239 O HOH H 2361 2.02
REMARK 500 O HOH H 2263 O HOH H 2264 2.09
REMARK 500 SG CYS H 220 O HOH H 2325 2.13
REMARK 500 O HOH H 2047 O HOH H 2076 2.16
REMARK 500 O HOH H 2072 O HOH L 2009 2.18
REMARK 500 O TRP H 61 O HOH H 2104 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 HIS H 71 -72.17 -146.45
REMARK 500 THR H 129C -58.08 -121.79
REMARK 500 SER H 170H 139.37 -36.88
REMARK 500 SER H 214 -65.71 -122.05
REMARK 500 GLN L 100 -104.46 -124.04
REMARK 500 THR L 108 49.86 -78.52
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH H2001 DISTANCE = 6.40 ANGSTROMS
REMARK 525 HOH H2030 DISTANCE = 5.84 ANGSTROMS
REMARK 525 HOH H2033 DISTANCE = 7.78 ANGSTROMS
REMARK 525 HOH H2038 DISTANCE = 6.02 ANGSTROMS
REMARK 525 HOH H2066 DISTANCE = 6.70 ANGSTROMS
REMARK 525 HOH H2128 DISTANCE = 5.86 ANGSTROMS
REMARK 525 HOH L2012 DISTANCE = 6.74 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA H1260 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 GLU H 70 OE1
REMARK 620 2 ASP H 72 O 85.4
REMARK 620 3 GLU H 75 O 133.1 76.9
REMARK 620 4 GLU H 80 OE2 111.7 161.0 85.0
REMARK 620 5 HOH H2122 O 80.7 98.2 59.9 77.5
REMARK 620 6 HOH H2139 O 105.7 78.8 112.7 103.2 172.6
REMARK 620 N 1 2 3 4 5
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 H1259
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA H1260
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 346 H1258
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1BF9 RELATED DB: PDB
REMARK 900 N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES
REMARK 900 RELATED ID: 1CVW RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR
REMARK 900 VIIA (DES-GLA)
REMARK 900 RELATED ID: 1DAN RELATED DB: PDB
REMARK 900 COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR
REMARK 900 VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR
REMARK 900 RELATED ID: 1DVA RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE
REMARK 900 INHIBITOR E-76 AND COAGULATION FACTOR VIIA
REMARK 900 RELATED ID: 1F7E RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR,
REMARK 900 20 STRUCTURES
REMARK 900 RELATED ID: 1F7M RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR,
REMARK 900 MINIMIZED AVERAGE STRUCTURE
REMARK 900 RELATED ID: 1FAK RELATED DB: PDB
REMARK 900 HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA
REMARK 900 INHIBITED WITH A BPTI-MUTANT
REMARK 900 RELATED ID: 1FF7 RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII
REMARK 900 (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES
REMARK 900 RELATED ID: 1FFM RELATED DB: PDB
REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII
REMARK 900 (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE
REMARK 900 RELATED ID: 1J9C RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
REMARK 900 RELATED ID: 1JBU RELATED DB: PDB
REMARK 900 COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE ) IN COMPLEXWITH
REMARK 900 INHIBITORY EXOSITE PEPTIDE A -183
REMARK 900 RELATED ID: 1KLI RELATED DB: PDB
REMARK 900 COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA
REMARK 900 RELATED ID: 1KLJ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA
REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB
REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX
REMARK 900 RELATED ID: 1O5D RELATED DB: PDB
REMARK 900 DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTSAT THE
REMARK 900 S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190UPA)
REMARK 900 RELATED ID: 1QFK RELATED DB: PDB
REMARK 900 STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE
REMARK 900 TRIGGERING OF BLOOD COAGULATION
REMARK 900 RELATED ID: 1W0Y RELATED DB: PDB
REMARK 900 TF7A_3771 COMPLEX
REMARK 900 RELATED ID: 1W2K RELATED DB: PDB
REMARK 900 TF7A_4380 COMPLEX
REMARK 900 RELATED ID: 1W7X RELATED DB: PDB
REMARK 900 FACTOR7 - 413 COMPLEX
REMARK 900 RELATED ID: 1W8B RELATED DB: PDB
REMARK 900 FACTOR7 - 413 COMPLEX
REMARK 900 RELATED ID: 1YGC RELATED DB: PDB
REMARK 900 SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR
REMARK 900 RELATED ID: 1Z6J RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTORVIIA/TISSUE FACTOR/
REMARK 900 PYRAZINONE INHIBITOR
DBREF 2BZ6 H 16 257 UNP P08709 FA7_HUMAN 213 466
DBREF 2BZ6 L 90 142 UNP P08709 FA7_HUMAN 150 202
SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO
SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS
SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA
SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU
SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP
SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE
SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE
SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP
SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER
SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER
SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU
SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN
SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO
SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP
SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO
SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY
SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS
SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP
SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL
SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO
SEQRES 1 L 53 ILE CYS VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS
SEQRES 2 L 53 SER ASP HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS
SEQRES 3 L 53 GLU GLY TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR
SEQRES 4 L 53 PRO THR VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU
SEQRES 5 L 53 GLU
HET 346 H1258 54
HET SO4 H1259 5
HET CA H1260 1
HETNAM 346 (R)-(4-CARBAMIMIDOYL-PHENYLAMINO)-[5-ETHOXY-2-FLUORO-3-
HETNAM 2 346 [(R)-TETRAHYDRO-FURAN-3-YLOXY]-PHENYL]-ACETIC ACID
HETNAM SO4 SULFATE ION
HETNAM CA CALCIUM ION
HETSYN 346 (2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-
HETSYN 2 346 FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETIC
HETSYN 3 346 ACID
FORMUL 3 346 C21 H24 F N3 O5
FORMUL 4 SO4 O4 S 2-
FORMUL 5 CA CA 2+
FORMUL 6 HOH *500(H2 O)
HELIX 1 1 ALA H 55 ASP H 60 5 6
HELIX 2 2 ASN H 60D ARG H 62 5 3
HELIX 3 3 GLU H 125 THR H 129C 1 8
HELIX 4 4 LEU H 129D VAL H 129G 5 4
HELIX 5 5 MET H 164 SER H 170B 1 9
HELIX 6 6 CYS H 191 SER H 195 5 5
HELIX 7 7 TYR H 234 ARG H 243 1 10
HELIX 8 8 ASN L 93 CYS L 98 5 6
SHEET 1 HA 9 LYS H 20 VAL H 21 0
SHEET 2 HA 9 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20
SHEET 3 HA 9 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163
SHEET 4 HA 9 GLY H 226 ARG H 230 -1 O GLY H 226 N ALA H 183
SHEET 5 HA 9 THR H 206 TRP H 215 -1 O ILE H 212 N THR H 229
SHEET 6 HA 9 PRO H 198 TYR H 203 -1 O HIS H 199 N THR H 210
SHEET 7 HA 9 PHE H 135 GLY H 140 -1 O LEU H 137 N ALA H 200
SHEET 8 HA 9 MET H 156 LEU H 163 1 O MET H 156 N GLY H 140
SHEET 9 HA 9 LYS H 20 VAL H 21 -1 O LYS H 20 N VAL H 157
SHEET 1 HB 9 GLN H 30 VAL H 35 0
SHEET 2 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35
SHEET 3 HB 9 TRP H 51 SER H 54 -1 O VAL H 53 N THR H 45
SHEET 4 HB 9 ALA H 104 LEU H 108 -1 O ALA H 104 N SER H 54
SHEET 5 HB 9 GLN H 81 PRO H 91 1 N ALA H 86 O ARG H 107
SHEET 6 HB 9 LEU H 64 LEU H 68 -1 O LEU H 64 N VAL H 85
SHEET 7 HB 9 GLN H 30 VAL H 35 -1 O LEU H 32 N VAL H 67
SHEET 8 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35
SHEET 9 HB 9 GLN H 30 VAL H 35 -1 O VAL H 31 N GLY H 44
SHEET 1 LA 2 TYR L 101 HIS L 105 0
SHEET 2 LA 2 LYS L 109 ARG L 113 -1 O LYS L 109 N HIS L 105
SHEET 1 LB 2 TYR L 118 LEU L 120 0
SHEET 2 LB 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119
SSBOND 1 CYS H 22 CYS H 27 1555 1555 2.04
SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.04
SSBOND 3 CYS H 122 CYS L 135 1555 1555 2.02
SSBOND 4 CYS H 168 CYS H 182 1555 1555 2.04
SSBOND 5 CYS H 191 CYS H 220 1555 1555 2.04
SSBOND 6 CYS L 91 CYS L 102 1555 1555 2.05
SSBOND 7 CYS L 98 CYS L 112 1555 1555 2.04
SSBOND 8 CYS L 114 CYS L 127 1555 1555 2.05
LINK OE1 GLU H 70 CA CA H1260 1555 1555 2.34
LINK O ASP H 72 CA CA H1260 1555 1555 2.57
LINK O GLU H 75 CA CA H1260 1555 1555 2.51
LINK OE2 GLU H 80 CA CA H1260 1555 1555 2.59
LINK CA CA H1260 O HOH H2122 1555 1555 3.11
LINK CA CA H1260 O HOH H2139 1555 1555 3.25
CISPEP 1 PHE H 256 PRO H 257 0 0.63
SITE 1 AC1 8 MET H 164 THR H 165 ARG H 230 HOH H2401
SITE 2 AC1 8 HOH H2402 HOH H2403 HOH H2404 HOH H2405
SITE 1 AC2 4 GLU H 70 ASP H 72 GLU H 75 GLU H 80
SITE 1 AC3 17 HIS H 57 THR H 98 THR H 99 ASP H 102
SITE 2 AC3 17 ASP H 189 SER H 190 LYS H 192 SER H 195
SITE 3 AC3 17 SER H 214 TRP H 215 GLY H 216 GLN H 217
SITE 4 AC3 17 GLY H 219 HOH H2340 HOH H2348 HOH H2395
SITE 5 AC3 17 HOH H2398
CRYST1 94.930 94.930 115.640 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010534 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010534 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008648 0.00000